Luisa Hector
Stock Analyst at Berenberg Bank
(3.69)
# 2,093
Out of 5,010 analysts
294
Total ratings
58.6%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 340.00 → CHF 350.00 | CHF 355.40 | -1.52% | 53 | Sep 23, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 16,000p → 15,000p | 12,492p | +20.08% | 74 | Sep 14, 2026 | |
| LLY Eli Lilly and Company | Upgraded: Buy | $1,400 | $1,184.78 | +18.17% | 1 | Sep 14, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $275 | $266.28 | +3.27% | 20 | Sep 10, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €105.00 | €72.00 | +45.83% | 53 | Aug 24, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $125 → $127 | $148.69 | -14.59% | 35 | Aug 5, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | CHF 121.40 | -9.39% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Reiterated: Hold | 414p | 345p | +19.93% | 1 | Feb 11, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,660p | 1,860p | -10.75% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Reiterated: Buy | $63 → $67 | $41.18 | n/a | 11 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $60 | $63.88 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €197.00 | €138.45 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $28.72 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €77.50 | €50.80 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.46 | n/a | 2 | Sep 15, 2016 |
Roche Holding AG
Sep 23, 2026
Reiterated: Hold
Price Target: CHF 340.00 → CHF 350.00
Current: CHF 355.40
Upside: -1.52%
AstraZeneca PLC
Sep 14, 2026
Reiterated: Buy
Price Target: 16,000p → 15,000p
Current: 12,492p
Upside: +20.08%
Eli Lilly and Company
Sep 14, 2026
Upgraded: Buy
Price Target: $1,400
Current: $1,184.78
Upside: +18.17%
AbbVie
Sep 10, 2026
Reiterated: Buy
Price Target: $275
Current: $266.28
Upside: +3.27%
Sanofi
Aug 24, 2026
Reiterated: Buy
Price Target: €105.00
Current: €72.00
Upside: +45.83%
Merck & Co.
Aug 5, 2026
Reiterated: Hold
Price Target: $125 → $127
Current: $148.69
Upside: -14.59%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: CHF 121.40
Upside: -9.39%
Barratt Redrow plc
Feb 11, 2026
Reiterated: Hold
Price Target: 414p
Current: 345p
Upside: +19.93%
GSK plc
Jan 6, 2026
Reiterated: Hold
Price Target: 1,660p
Current: 1,860p
Upside: -10.75%
Sanofi
May 16, 2025
Reiterated: Buy
Price Target: $63 → $67
Current: $41.18
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: $55 → $60
Current: $63.88
Upside: n/a
Feb 10, 2022
Reiterated: Hold
Price Target: €197.00
Current: €138.45
Upside: n/a
Jun 14, 2021
Reiterated: Hold
Price Target: $43
Current: $28.72
Upside: n/a
Sep 11, 2018
Reiterated: Hold
Price Target: €77.50
Current: €50.80
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $14.46
Upside: n/a